Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 53 in last 24h · 115,243 total before filter · latest 52m ago
53last 24h
1810last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro323Earnings856M&A105Regulatory25Product16Analyst25
✕ clear all filtersticker: AMGNSentiment:bullishneutralbearishshow all (incl. clickbait)
Jobs Numbers, SpaceX Earnings: What to Watch This Week
The Wall Street Journal12d agoneutral
Jobs Numbers, SpaceX Earnings: What to Watch This Week

The monthly jobs report comes out Friday. Before that, Elon Musk’s SpaceX will post its first earnings report as a listed company. Also reporting: Walt Disney; tech companies Palantir and Advanced Micro Devices; ride-sharing firms Uber and Lyft; private-equity firms Apollo, Carlyle and TPG; and fast-food chains McDonald's and Wendy’s.

Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel
Reuters45d agoneutral
Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel

July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move ‌by a U. In granting a preliminary injunction, Chief Judge Daniel Domenico ‌of the Denver federal court said Amgen would likely face significant and irreparable harm from charging lower prices, ​adding that it could affect the drugmaker's negotiations for future contracts with wholesalers and distributors.